Phase I and pharmacologic study of BMS-181174 given as a 6 h infusion every 4 weeks to patients with advanced solid tumors.
暂无分享,去创建一个
J. Verweij | J. Schellens | G. Stoter | B. Winograd | M. V. D. Van Der Burg | A. Planting | M. de Boer-Dennert
暂无分享,去创建一个
J. Verweij | J. Schellens | G. Stoter | B. Winograd | M. V. D. Van Der Burg | A. Planting | M. de Boer-Dennert